Medicine and Dentistry
Ganglioneuroblastoma
100%
Neoplasm
52%
Urinary System
47%
Solid Malignant Neoplasm
26%
Patient with Neuroblastoma
26%
Biological Marker
26%
3-Methoxytyramine
26%
RNA Sequence
23%
Immunotherapy
23%
Transplantation
23%
Breast Cancer
23%
Diseases
23%
Neuroblastoma Cell Line
23%
Pediatrics
23%
Drug Sensitivity
23%
Personalized Medicine
23%
Liquid Biopsy
23%
Catecholamine
23%
Transcriptomics
23%
Organoid
23%
High Throughput Screening
17%
Clinical Decision Making
14%
Tumor
12%
Programmed Death-Ligand 1
9%
T Cell
9%
Organ Donor
9%
Cell Line
8%
Prognostication
8%
Rhabdomyosarcoma
8%
Overall Survival
8%
Pediatrics Patient
7%
Primary Tumor
6%
Messenger RNA
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Decision Making
5%
In Vitro
5%
Genome Sequencing
5%
Venetoclax
5%
Droplet Digital Polymerase Chain Reaction
5%
Drug Screening
5%
Treatment Response
5%
Keyphrases
Neuroblastoma
78%
High-risk Neuroblastoma
29%
Complete Remission
29%
3-methoxytyramine
27%
TIGIT
23%
Nectin-2
23%
Single-cell RNA Sequencing (scRNA-seq)
23%
Integrative Analysis
23%
Patient Characteristics
23%
Aberrations
23%
Tumor Characteristics
23%
Multiorgan Donor
23%
Mutational Spectrum
23%
Breast Cancer
23%
Transplant Recipients
23%
Urinary Catecholamines
23%
Catecholamines
20%
Spot Urine
16%
Immunomodulatory
11%
Complete Response
11%
Tumor
11%
Exon Deletion
10%
Overall Survival
10%
Poor Prognosis
9%
Missense
6%
ATRX mutation
6%
In Vitro Diagnostics
6%
Event-free Survival
6%
Clinical High Risk
6%
Working Diagnosis
6%
B Cells
5%
Immune Checkpoint
5%
Combination Strategy
5%
Pediatric Patients
5%
Treatment Options
5%
Effective Treatment
5%
Interaction Analysis
5%
Programmed Death-ligand 1 (PD-L1)
5%
Syngeneic Model
5%
NKT Cells
5%
Immunotherapy Efficacy
5%
Immunotherapeutics
5%
Promising Target
5%
Poor Survival
5%
Post-chemotherapy
5%
Chemotherapy Resistance
5%
Survival Rate
5%
T Cells
5%
Reduced Cytotoxicity
5%
Relapse Prevention
5%
